Clinical Trial: Preoperative Octreotide Treatment of Acromegaly

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Preoperative Octreotide Treatment of Patients With Growth Hormone Producing Pituitary Adenomas

Brief Summary: The purpose of this study is to investigate whether 6 months preoperative treatment with the somatostatin analogue octreotide improves the surgical outcome in patients with acromegaly.